Lineage Cell Therapeutics LCTX

$ 0.55 9.22%

Quarterly report 2024-Q3
added 11-14-2024

Lineage Cell Therapeutics EV/EBITDA Ratio 2011-2024 | LCTX

Annual EV/EBITDA Ratio Lineage Cell Therapeutics

2021	2020	2019	2018	2017	2016	2015	2014	2013	2012	2011
-0.578	-12.3	-4.09	-4.15	-8.09	-5.05	-2.54	-5.72	-5.88	-9.84	-15.7

All numbers in USD currency

Indicator range from annual reports

Maximum	Minimum	Average
-0.578	-15.7	-6.73